Explore by Goal

Quick Explanation Copied

Author snapshot: Kelly E. Ormond

Highly-cited genetic-counseling and genomics ethics researcher with sustained publication activity since the 1990s, major contributions to ACMG guidance and prenatal/genomic counseling literature — bibliometrics from OpenAlex show ~186 works, ~12.8k citations, h-index ≈45 (counts-by-year provided below) ^(sources).

Key sources: OpenAlex author profile (works_count, cited_by_count, h_index; counts_by_year) and OpenAlex top works listing (ACMG/consensus publications) which illustrate high-impact policy contributions.

All claims below are sourced and linked inline.

Long Explanation

Author Review — Kelly E. Ormond

Visualizations first; brief, evidence-linked critique second. All metrics and claims are inline-sourced.

Data source: OpenAlex 'counts_by_year' for Kelly E. Ormond (profile A5004214543) — raw yearly works_count and cited_by_count plotted here. Source linked in citations below.

These items come from OpenAlex 'top_works' (paper-level citation counts) and demonstrate policy/guideline influence in medical genetics and genomic ethics.

Evidence-based summary (what the data show)

High productivity and influence: OpenAlex reports ~186 works and ~12.8k citations (h-index ≈45), indicating sustained and broad scholarly influence across genetics, counseling, and ethics
Policy and guideline leadership: Ormond is a named author on major consensus/guideline outputs (e.g., ACMG recommendations for reporting incidental/secondary findings; American Journal of Human Genetics 'Points to Consider') that are highly cited and influential in clinical genomics practice
Interdisciplinary focus: Publications span clinical genetics, prenatal screening, genetic counseling workforce/global state, ethics of gene editing, data governance, and communication — signaling breadth and translational orientation rather than narrow laboratory bench work

Critical appraisal (strengths, blindspots, limitations)

Strengths — (1) Clear policy and translational impact evidenced by authorship on high-citation consensus statements and guideline documents; (2) sustained publication rate for >25 years with collaborative, multi-author high-impact work; (3) topical breadth covering ethics, counseling practice, prenatal genomics, and data governance — this breadth increases societal relevance and interdisciplinary reach .

Potential blindspots / limitations — (1) Much of the high-impact work is consensus/guideline or qualitative/ethical/policy analysis rather than large randomized trials or mechanistic bench research; that is appropriate for the field (genetic counseling/ethics) but means influence is primarily translational and normative rather than experimental; (2) co-authorship on multi-author consensus papers complicates attribution of specific intellectual contributions (common in guideline work); (3) bibliometric indicators (h-index, citation counts) reward consensus/guideline documents and reviews; they don’t capture reproducibility/experimental rigor in basic science — interpret metrics in disciplinary context to avoid cross-field miscomparison .

Conflicts / bias considerations — public data do not indicate financial conflicts or industry sponsorship across the set of visible works, but the presence of multi-stakeholder guideline development (academia, clinical societies) can entail potential stakeholder/advocacy influences; each guideline paper should be checked individually for declared conflicts in its author disclosures (not all bibliographic summaries carry COI details).

What would disprove or change this conclusion?

Evidence that Ormond’s listed contributions to guideline papers were nominal (e.g., only minor administrative edits) would reduce interpretation of leadership; conversely, documentation of lead-authorship or primary drafting on multiple high-citation guidelines would raise her evaluated policy leadership.
If independent reproducible empirical studies from Ormond’s group produced widely replicated causal/experimental findings, that would expand appraisal from translational/ethical impact into experimental scientific rigor.

Next actions / tools

Key source links and policy/guideline papers cited in this review are provided below.

Feedback:

Updated: March 17, 2026

BGPT Author Review

Scientific Quality

80%

Ormond scores highly (8/10) because her publication record shows high-impact translational and policy contributions in genomic medicine and genetic counseling (numerous consensus/guideline papers, sustained citations, and interdisciplinary reach). The score reflects strong intellectual influence and societal impact rather than bench-experimental novelty; potential limits are the normative/consensus nature of many top outputs and the collaborative authorship model which diffuses attribution.

Communication Quality

90%

Communication is excellent: many works are policy/guidance documents and reviews written for clinical and policy audiences, indicating clarity, accessibility, and influence in practitioner communities; frequent co-authorship on consensus statements implies effectiveness at multidisciplinary translation.

Author Novelty

60%

Novelty is moderate: work is innovative in applying ethical frameworks, governance, and workforce analysis to emerging genomic practice, but much of it is synthesis, policy guidance, and translational application rather than wholly new basic-science discoveries.

Scientific Rigor

70%

Rigor is generally good for the disciplinary norms (systematic reviews, mixed-methods, qualitative analyses, guideline development with evidence review). Scores reduced slightly because many outputs are consensus documents where scientific rigor depends on the underlying evidence base rather than novel experimental reproducibility.

Key Insight

Authors who bridge ethics, policy, and clinical genetics can achieve outsized influence through consensus/guideline authorship; bibliometrics show Ormond’s impact is primarily translational and normative rather than mechanistic.

Keep Exploring

Retrieve and summarize declared conflicts of interest and author contributions for Ormond's top 10 cited papers.

Run a citation-network analysis to quantify Ormond's centrality in the genomic-ethics/guideline literature and identify close collaborators and fields of influence.

Analysis Wizard

Fetching OpenAlex author counts_by_year and top_works JSON and producing publication/citation time-series and citation-network edge lists for network analysis.

Hypothesis Graveyard

Hypothesis: Ormond’s high citation counts reflect purely self-citation and narrow community echo—Why falsified: top_works are multi-author consensus/guideline papers widely cited across disciplines, not isolated to a single group.

Hypothesis: Bibliometrics overstate impact because publications are commentary-only—Why weakened: many listed works are formal consensus/guidelines and empirical mixed-methods studies with substantive evidence reviews.

Potential Experiments

Compare clinical adoption rates of ACMG recommendations across hospitals with vs without Ormond-affiliated training programs in genetic counseling to test the causal role of workforce leadership in guideline uptake.

Perform a citation-network centrality analysis of authors on ACMG/guideline papers to quantify individual influence (betweenness, eigenvector centrality) and correlate with subsequent policy adoption metrics.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize bibliometric and guideline influence metrics and may underweight non-published community impact or unpublished leadership activities.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.